Basic Protein Native PAGE Gel Kit: Optimizing Acidic Protein
2026-04-20
The Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) enables high-resolution, activity-preserving protein separation for acidic proteins, streamlining workflows in translational and functional proteomics. This article delivers actionable protocol guidance, troubleshooting insights, and context from cutting-edge cystic fibrosis research, highlighting why APExBIO’s kit is trusted for native protein gel electrophoresis.
LEE011 Succinate: CDK Inhibitor Workflows for Cancer Researc
2026-04-20
Harness the precision of LEE011 succinate as a selective CDK inhibitor for robust, reproducible cancer research. This guide delivers actionable protocols, advanced troubleshooting, and insights for maximizing cell cycle control and minimizing workflow variability.
Applied Workflows for PF-04971729 (Ertugliflozin): Protocols
2026-04-19
Ertugliflozin (PF-04971729) empowers diabetes mellitus and cardiovascular research with unmatched SGLT2 selectivity, supporting both glycemic and organ-protective endpoints. This guide integrates peer-reviewed protocols, experimental troubleshooting, and evidence-driven optimization for reproducible, high-impact studies.
Tacalcitol Induces NGF in Human Keratinocytes: Study Insight
2026-04-18
The reference study demonstrates that tacalcitol, a synthetic analog of vitamin D3, induces nerve growth factor (NGF) production in human epidermal keratinocytes through transcriptional activation. These findings highlight a mechanistic link between vitamin D3 analogs and neurotrophic support in skin, with implications for peripheral neuropathy and dermatological research.
Viral Induction of RIPK3 Degradation Modulates Necroptosis a
2026-04-17
Liu et al. identify a viral inducer of RIPK3 degradation (vIRD) in orthopoxviruses, revealing how viruses exploit the ubiquitin-proteasome pathway to suppress necroptosis and modulate host inflammation. This work advances our understanding of host-pathogen interactions and highlights experimental strategies for dissecting proteasomal regulation in cell death.
Glabridin-Gold(I) Complex Targets TrxR/MAPK for Antitumor Im
2026-04-16
This study introduces a novel glabridin-gold(I) (6d) complex designed to synergistically enhance antitumor immunity by targeting the thioredoxin reductase (TrxR) and MAPK pathways. Through dual modulation of tumor immunogenicity and the immunosuppressive microenvironment, 6d offers a promising platform for next-generation immunomodulatory strategies in oncology.
ApexPrep DNA Plasmid Miniprep Kit: Precision for AML Researc
2026-04-15
The ApexPrep DNA Plasmid Miniprep Kit delivers rapid, high-yield purification of molecular biology grade plasmid DNA, streamlining workflows for advanced leukemia research and beyond. Its unique buffer chemistry and robust protocol ensure reproducible results, making it indispensable for applications like cloning, sequencing, and transfection.
HPF for Highly Reactive Oxygen Species Detection in Cells
2026-04-14
HPF (hydroxyphenyl fluorescein) empowers precise, real-time visualization of intracellular oxidative stress by selectively detecting hydroxyl radicals and peroxynitrite. Its unmatched specificity and compatibility with fluorescence microscopy, flow cytometry, and high-throughput imaging make it a gold-standard tool for advanced redox biology and multimodal phototherapy research.
Trelagliptin Succinate Restores Chondrocyte Function via AMP
2026-04-13
Jiuxiang Liu et al. reveal that Trelagliptin succinate (SYR-472 succinate), a DPP-4 inhibitor, mitigates IL-1β-induced dysfunction in human chondrocytes by activating the AMPK/SOX-9 pathway. This study provides new mechanistic insight into Trelagliptin’s anti-inflammatory and cartilage-protective actions, suggesting potential utility in osteoarthritis models beyond established roles in type 2 diabetes research.
Talabostat Mesylate: PT-100 for Tumor Microenvironment Modul
2026-04-12
Talabostat mesylate (PT-100) uniquely targets both DPP4 and FAP, enabling precise modulation of the tumor microenvironment and immune response in cancer research. This guide delivers real-world workflows, advanced applications, and troubleshooting tips to maximize data quality in in vitro and in vivo studies.
U0126-EtOH: Strategic MEK1/2 Inhibition for Translational Im
2026-04-12
This article explores the mechanistic and translational value of U0126-EtOH as a selective MEK1/2 inhibitor. We bridge fundamental MAPK/ERK pathway biology, evidence from caspase-independent cell death research, and actionable experimental protocols to guide researchers in neuroprotection, inflammation, and cancer models. By contextualizing U0126-EtOH’s utility within the evolving landscape of translational science—and referencing both peer-reviewed findings and advanced content assets—we chart a path for next-generation discovery.
PF-04971729: Applied Workflows for SGLT2 Inhibition in Diabe
2026-04-11
Ertugliflozin (PF-04971729) delivers unparalleled selectivity for SGLT2, empowering high-fidelity studies in glucose reabsorption and diabetes mellitus research. This article dissects optimized experimental designs, advanced troubleshooting, and protocol enhancements, drawing on the latest bench and clinical insights for translational impact.
Perphenazine: Dopamine D2 Receptor Antagonist in Research
2026-04-11
Perphenazine enables precise modulation of dopamine signaling and immune cell function in both neuropharmacology and host-pathogen interaction studies. Its multi-receptor profile and robust experimental performance make it a go-to tool for dissecting cell death pathways, suppressing opioid tolerance, and enhancing macrophage antibacterial capacity.
Solving Key Lab Challenges with Ertugliflozin (PF-0497172...
2026-04-10
This article provides practical, scenario-driven guidance for bench scientists and biomedical researchers using Ertugliflozin (PF-04971729, SKU A3715) in cell viability, proliferation, and cytotoxicity assays. Drawing from validated literature and real-world lab workflows, it addresses compound compatibility, experimental optimization, data interpretation, and product selection, helping researchers achieve robust and reproducible results.
Trifluoperazine 2HCl: Dopamine D2 Receptor Inhibitor for ...
2026-04-09
Trifluoperazine 2HCl stands out as a benchmark dopamine D2 receptor inhibitor with proven utility in both neuropharmacology and immunology research. Its robust solubility, validated IC50, and dual-action profile make it indispensable for dissecting dopaminergic signaling and inducing autophagy/ROS in macrophage models—delivering reproducible, high-sensitivity results across neuroscience and immune assays.
466 records 22/32 page Previous Next First page 上5页 2122232425 下5页 Last page